Many people notice reduced hunger early on, with visible weight loss typically starting around 4 to 8 weeks into treatment and continuing as the dose is increased toward the 25 mg maintenance level
(Folate deficiency disrupts normal DNA synthesis and methylation, which interferes with cell division and development, especially in rapidly dividing embryos.) Megaloblastic anemia, which can lead to symptoms like fatigue, weakness, and difficulty concentrating Elevated homocysteine, even when B12 levels are normal
Oral glutathione supplements face significant absorption challenges due to breakdown by digestive enzymes and poor intestinal permeability for the intact molecule
Preservation of lean muscle mass during weight loss
Erythropoietic Protoporphyria (EPP) Treatment: MT-I is FDA-approved as a treatment for EPP, demonstrating the ability to mitigate symptoms by increasing melanin in the skin, absorbing UV, and reducing skin damage and pain [5]